NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your Perpetua Resources Corp. (NASDAQ:PPTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/perpetua-resources-corp-lawsuit-submission-form?prid=148894&wire=1&utm_campaign=8 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your Napco Security Technologies, Inc. (NASDAQ:NSSC) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/napco-security-technologies-inc-lawsuit-submission-form-2?prid=148895&wire=1&utm_campaign=3 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Organon & Co. ("Organon & Co.") (NYSE:OGN) concerning possible violations of federal securities laws. On May 1, 2025, Organon reported mixed Q1 FY25 results, missing expectations on revenue decline of 7% y/y to $1.51B.

- *6x Platinum*: SZA's "SOS" album sells 6M+ units, with 100M+ streams on Billboard-topping singles, driving significant recurring revenues.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cable One, Inc. ("Cable One, Inc.") (NYSE:CABO) concerning possible violations of federal securities laws. On May 2, 2025, Cable One missed earnings expectations by nearly $8 and suspended its dividend.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cytokinetics, Incorporated ("Cytokinetics, Incorporated") (NASDAQ:CYTK) concerning possible violations of federal securities laws. BioPharma Dive published a report on Cytokinetics on May 2, 2025, and stated that, "The Food and Drug Administration has delayed an approval decision on Cytokinetics' experimental hypertrophic obstructive cardiomyopathy drug aficamten so it can have more time to review the company's proposed risk management plan.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of EchoStar Corporation ("EchoStar Corporation") (NASDAQ:SATS) concerning possible violations of federal securities laws. The Wall Street Journal reported on May 12, 2025, that the Federal Communications Commission had notified EchoStar that it would be investigating the Company's compliance with federal requirements to build a nationwide 5G network.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Cleveland-Cliffs Inc. ("Cleveland-Cliffs Inc.") (NYSE:CLF) concerning possible violations of federal securities laws. Cleveland-Cliffs issued a press release on May 7, 2025, reporting its financial results for the first quarter of 2025.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / If you suffered a loss on your Compass Group Diversified Holdings, LLC (NYSE:CODI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/compass-diversified-lawsuit-submission-form?prid=148899&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq.

ROCHESTER, N.Y. , May 16, 2025 /PRNewswire/ -- Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of AI-powered smart glasses, waveguides, and Augmented Reality (AR) technologies, today acknowledged a public post made by Amazon on LinkedIn, which highlighted the use of Vuzix smart glasses to enhance warehouse operations.

BILZ offers capital preservation and liquidity by investing in ultra-short-term government debt, ideal for risk-averse investors amid rising default rates. Despite active management, BILZ's yield lags behind leading peers like SGOV, failing to deliver on its higher yield promise. Current macro risks, including elevated federal debt and default concerns, reinforce the need for safe, short-duration assets in portfolios.

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Myriad Genetics, Inc. ("Myriad Genetics, Inc.") (NASDAQ:MYGN) concerning possible violations of federal securities laws. Myriad released its first quarter 2025 financial results on May 6, 2025, revealing "revenue of $196 million declined by 3% year-over-year" and "pharmacogenomics revenue declined by 20% year-over-year due to UnitedHealthcare (UNH) reducing coverage of GeneSight®.

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Canopy Growth To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / If you suffered losses exceeding $50,000 in Canopy Growth between May 30, 2024 and February 6, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential …

NEW YORK, NY / ACCESS Newswire / May 16, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Ichor Holdings, Ltd. ("Ichor Holdings, Ltd.

Applied Materials Inc (NASDAQ:AMAT, ETR:AP2) topped Wall Street expectations for quarterly profit as strong demand for advanced semiconductors helped offset weakness in memory chips and trade-related headwinds in China. Adjusted earnings per share rose 14% to $2.39 in the fiscal second quarter ended April 28, surpassing analysts' average estimate of $2.31, according to LSEG data.

Despite competitive pressures in the obesity market, long-term investors may stay invested in NVO stock due to strong demand for its GLP-1 drugs.

GILT's Q1 2025 performance is likely to have benefited from a surge in defense deals, momentum in its IFC business and steady gains from acquisition synergies.

RBC Bearings (RBC) came out with quarterly earnings of $2.83 per share, beating the Zacks Consensus Estimate of $2.68 per share. This compares to earnings of $2.47 per share a year ago.

Year-ahead inflation expectations increased from 6.5% to 7.3%.

LOS ANGELES , May 16, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against West Pharmaceutical Services, Inc. ("West" or "the Company") (NYSE: WST) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between February 16, 2023 and February 12, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before July 7, 2025.